Consensus Statement on Proton Therapy for Prostate Cancer
Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Particle Therapy Co-operative Group
2021-04-01
|
| Series: | International Journal of Particle Therapy |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.14338/IJPT-20-00031.1 |
| _version_ | 1797204814907572224 |
|---|---|
| author | Curtis M. Bryant, MD, MPH Randal H. Henderson, MD, MBA R. Charles Nichols, MD William M. Mendenhall, MD Bradford S. Hoppe, MD, MPH Carlos E. Vargas, MD Thomas B. Daniels, MD C. Richard Choo, MD Rahul R. Parikh, MD Huan Giap, MD, PhD Jerry D. Slater, MD Neha Vapiwala, MD William Barrett, MD Akash Nanda, MD, PhD Mark V. Mishra, MD Seungtaek Choi, MD Jay J. Liao, MD Nancy P. Mendenhall, MD the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group |
| author_facet | Curtis M. Bryant, MD, MPH Randal H. Henderson, MD, MBA R. Charles Nichols, MD William M. Mendenhall, MD Bradford S. Hoppe, MD, MPH Carlos E. Vargas, MD Thomas B. Daniels, MD C. Richard Choo, MD Rahul R. Parikh, MD Huan Giap, MD, PhD Jerry D. Slater, MD Neha Vapiwala, MD William Barrett, MD Akash Nanda, MD, PhD Mark V. Mishra, MD Seungtaek Choi, MD Jay J. Liao, MD Nancy P. Mendenhall, MD the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group |
| author_sort | Curtis M. Bryant, MD, MPH |
| collection | DOAJ |
| description | Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective studies have been published documenting the efficacy and safety of proton therapy for patients with localized prostate cancer and for patients requiring adjuvant or salvage pelvic radiation after surgery. The Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee intends to address current proton therapy indications, advantages, disadvantages, and cost effectiveness. We will also discuss the current landscape of clinical trials. This consensus report can be used to guide clinical practice and research directions. |
| first_indexed | 2024-04-24T08:41:13Z |
| format | Article |
| id | doaj.art-871926a9f47046e99a4987b232eaa487 |
| institution | Directory Open Access Journal |
| issn | 2331-5180 |
| language | English |
| last_indexed | 2024-04-24T08:41:13Z |
| publishDate | 2021-04-01 |
| publisher | Particle Therapy Co-operative Group |
| record_format | Article |
| series | International Journal of Particle Therapy |
| spelling | doaj.art-871926a9f47046e99a4987b232eaa4872024-04-16T16:07:59ZengParticle Therapy Co-operative GroupInternational Journal of Particle Therapy2331-51802021-04-018211610.14338/IJPT-20-00031.1i2331-5180-8-2-1Consensus Statement on Proton Therapy for Prostate CancerCurtis M. Bryant, MD, MPH0Randal H. Henderson, MD, MBA1R. Charles Nichols, MD2William M. Mendenhall, MD3Bradford S. Hoppe, MD, MPH4Carlos E. Vargas, MD5Thomas B. Daniels, MD6C. Richard Choo, MD7Rahul R. Parikh, MD8Huan Giap, MD, PhD9Jerry D. Slater, MD10Neha Vapiwala, MD11William Barrett, MD12Akash Nanda, MD, PhD13Mark V. Mishra, MD14Seungtaek Choi, MD15Jay J. Liao, MD16Nancy P. Mendenhall, MD17the Genitourinary Subcommittee of the Particle Therapy Co-Operative GroupDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USADepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USADepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USADepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USADepartment of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USADepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USADepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USADepartment of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, USADepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USADepartment of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USADepartment of Radiation Oncology, Loma Linda University, Loma Linda, CA, USADepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USADepartment of Radiation Oncology, University of Cincinnati, Cincinnati, OH, USADepartment of Radiation Oncology, Orlando Health, Orlando, FL, USADepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USADepartment of Radiation Oncology, University of Washington Medical Center, Seattle, WA, USADepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USAProton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective studies have been published documenting the efficacy and safety of proton therapy for patients with localized prostate cancer and for patients requiring adjuvant or salvage pelvic radiation after surgery. The Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee intends to address current proton therapy indications, advantages, disadvantages, and cost effectiveness. We will also discuss the current landscape of clinical trials. This consensus report can be used to guide clinical practice and research directions.https://theijpt.org/doi/pdf/10.14338/IJPT-20-00031.1prostate cancerradiation therapyproton therapyparticle therapy |
| spellingShingle | Curtis M. Bryant, MD, MPH Randal H. Henderson, MD, MBA R. Charles Nichols, MD William M. Mendenhall, MD Bradford S. Hoppe, MD, MPH Carlos E. Vargas, MD Thomas B. Daniels, MD C. Richard Choo, MD Rahul R. Parikh, MD Huan Giap, MD, PhD Jerry D. Slater, MD Neha Vapiwala, MD William Barrett, MD Akash Nanda, MD, PhD Mark V. Mishra, MD Seungtaek Choi, MD Jay J. Liao, MD Nancy P. Mendenhall, MD the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group Consensus Statement on Proton Therapy for Prostate Cancer International Journal of Particle Therapy prostate cancer radiation therapy proton therapy particle therapy |
| title | Consensus Statement on Proton Therapy for Prostate Cancer |
| title_full | Consensus Statement on Proton Therapy for Prostate Cancer |
| title_fullStr | Consensus Statement on Proton Therapy for Prostate Cancer |
| title_full_unstemmed | Consensus Statement on Proton Therapy for Prostate Cancer |
| title_short | Consensus Statement on Proton Therapy for Prostate Cancer |
| title_sort | consensus statement on proton therapy for prostate cancer |
| topic | prostate cancer radiation therapy proton therapy particle therapy |
| url | https://theijpt.org/doi/pdf/10.14338/IJPT-20-00031.1 |
| work_keys_str_mv | AT curtismbryantmdmph consensusstatementonprotontherapyforprostatecancer AT randalhhendersonmdmba consensusstatementonprotontherapyforprostatecancer AT rcharlesnicholsmd consensusstatementonprotontherapyforprostatecancer AT williammmendenhallmd consensusstatementonprotontherapyforprostatecancer AT bradfordshoppemdmph consensusstatementonprotontherapyforprostatecancer AT carlosevargasmd consensusstatementonprotontherapyforprostatecancer AT thomasbdanielsmd consensusstatementonprotontherapyforprostatecancer AT crichardchoomd consensusstatementonprotontherapyforprostatecancer AT rahulrparikhmd consensusstatementonprotontherapyforprostatecancer AT huangiapmdphd consensusstatementonprotontherapyforprostatecancer AT jerrydslatermd consensusstatementonprotontherapyforprostatecancer AT nehavapiwalamd consensusstatementonprotontherapyforprostatecancer AT williambarrettmd consensusstatementonprotontherapyforprostatecancer AT akashnandamdphd consensusstatementonprotontherapyforprostatecancer AT markvmishramd consensusstatementonprotontherapyforprostatecancer AT seungtaekchoimd consensusstatementonprotontherapyforprostatecancer AT jayjliaomd consensusstatementonprotontherapyforprostatecancer AT nancypmendenhallmd consensusstatementonprotontherapyforprostatecancer AT thegenitourinarysubcommitteeoftheparticletherapycooperativegroup consensusstatementonprotontherapyforprostatecancer |